뉴스
-
Lemon Healthcare's Wild Debut, Vivozon's Clinical Boost [K-bio pulse]
On July 6, the pharmaceutical and biotechnology industry saw newly listed Lemon Healthcare experience a rollercoaster ride, surging early before plummeting. Peo
www.edaily.co.kr · 2026.07.07
-
[K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead...
Despite the "Black Tuesday" selloff on July 28, several biotech stocks bucked the broader market. As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit
www.edaily.co.kr · 2026.07.29
-
i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse]
South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting second quarter earnings that far exceeded market exp
www.edaily.co.kr · 2026.07.28
-
Deepnoid and Peptron Hit Daily Limit, L&C Bio Falls on Rights Offering[K-Bio Pulse]
South Korea's pharmaceutical and biotechnology sector received a boost on Aug. 3 as the KOSDAQ market posted strong gains. Buying momentum intensified, triggeri
www.edaily.co.kr · 2026.08.04
-
Antrogen Slides on Japan Fears, Hanmi Science Gains[K-Bio Pulse]
South Korean biopharmaceutical stocks moved in opposite directions on Tuesday, with Antrogen tumbling to the daily limit on concerns over the commercial potenti
www.edaily.co.kr · 2026.07.09
-
Vaxcell, Biggest Beneficiary of Regenerative Medicine Reform[K-Bio Pulse]
On the 29th, South Korea's pharmaceutical and life sciences sectors posted strong gains. The pharmaceutical index rose 9.52%, with 143 of 160 listed companies a
www.edaily.co.kr · 2026.06.30
-
Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse]
The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended
www.edaily.co.kr · 2026.07.14
-
BL Pharmtech Hits Daily Limit…Samchundang Pharm Falls[K-bio pulse]
Investors in the biopharmaceutical sector continued to show strong interest in BL Pharmtech on July 2, driving its stock to the daily upper limit. The surge was
www.edaily.co.kr · 2026.07.03
-
InBody Rallies on GLP-1 Buzz, Cellid Sinks[K-Bio Pulse]
Shares of South Korean biotech companies moved sharply in different directions on Monday as company-specific developments drove investor sentiment. InBody exten
www.edaily.co.kr · 2026.07.01
-
HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse]
On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains
www.edaily.co.kr · 2026.07.16
